Reuters logo
2 个月前
BRIEF-Athenex submits IND application of oraxol to Chinese FDA
2017年7月5日 / 上午11点11分 / 2 个月前

BRIEF-Athenex submits IND application of oraxol to Chinese FDA

July 5 (Reuters) - Athenex Inc

* Athenex Inc announces submission of investigational new drug application of oraxol to Chinese FDA

* Says application has been accepted by Chinese FDA for review

* Athenex Inc - Chinese subsidiary submitted an investigational new drug application to Chinese FDA for oraxol, an oral formulation of paclitaxel Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below